Welcome to our dedicated page for HEALTHLYNKED NEW SEC filings (Ticker: HLYKD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHLYNKED NEW's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHLYNKED NEW's regulatory disclosures and financial reporting.
HealthLynked Corp., a Nevada-based healthcare technology company, reports its annual results and outlines a shift from owning clinics toward a predominantly digital, technology-enabled model. The company operates three divisions: Digital Healthcare (its cloud-based HealthLynked Network with AI-assisted tools, telemedicine, concierge services, Oohvie, and a prescription discount program), Health Services (now a single functional medicine practice slated for divestiture), and Medical Distribution (MedOfficeDirect, an asset-light online medical supplies marketplace).
Management discloses substantial doubt about the company’s ability to continue as a going concern, citing $37,136 in cash, a working capital deficit, significant accumulated losses, and the need for additional financing in the first half of 2026. The filing highlights heavy competition from large digital health, EMR, telemedicine, and big tech players, regulatory complexity across healthcare, privacy and billing laws, and reliance on Amazon Web Services. It also notes sizeable related-party convertible debt owed to CEO Dr. Michael Dent, which may create dilution and conflict-of-interest risks. To support payer-integration and value-based care pilots, HealthLynked entered an advisory arrangement with Palm Beach Accountable Care Organization in December 2025, though no revenue from such initiatives is assured.
HealthLynked Corp. filed a Form 12b-25 to notify investors that it will be late in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. The company states that it could not complete the Form 10-Q on time without unreasonable effort or expense because it needs additional time to finalize the financial statements for the report. HealthLynked anticipates filing the Form 10-Q within the five-day grace period allowed under Rule 12b-25 of the Securities Exchange Act of 1934.